Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Metformin Combined With Dapagliflozin on Serum IGF-1 Levels in Male Patients With Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT07778719 is registered in ClinicalTrials.gov with The 95th Hospital of Putian，Putian, Fujian, China as lead sponsor.

NCT NCT07778719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07778719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Metformin Combined With Dapagliflozin on Serum IGF-1 Levels in Male Patients With Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease
Lead sponsor
The 95th Hospital of Putian，Putian, Fujian, China
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
December 11, 2027
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease, type 2 diabetes